The proportion of Brazilian women over 20 living with obesity rose from 14.5 percent in 2003 to 30.2 percent in 2019, according to data from the national statistics institute IBGE, a shift that endocrinologists in São Paulo link directly to the metabolic disruption of the climacteric and menopause. The decline in oestrogen, they note, accelerates loss of muscle mass, lowers resting energy expenditure, and promotes abdominal fat deposition, even when dietary habits remain unchanged. This metabolic reset, combined with poorer sleep and rising insulin resistance, makes weight loss markedly more difficult and coincides with a surge in joint complaints.

Across Southeast Asia, clinicians report that joint stiffness and pain are among the most common—and most under-recognised—early signals of perimenopause. Indonesian health outlets describe women in their forties and fifties suddenly experiencing hot flushes, erratic cycles, and mood swings alongside knee and generalised joint aching that disrupts daily activity. Orthopaedic specialists in Jakarta caution that persistent knee pain lasting weeks despite rest, especially when accompanied by swelling, clicking, or difficulty climbing stairs, often signals osteoarthritis or meniscal damage rather than a transient hormonal symptom, and warrants imaging rather than self-treatment.

Viewed from Madrid and Buenos Aires, the conversation extends to the spine and upper body. Spanish physiotherapists attribute much low-back and neck pain to sedentary work and weakened stabilising muscles, recommending controlled-movement routines such as cat-cow, glute bridges, and bird-dog exercises to improve lumbar mobility and reduce pressure on vertebral discs. Pilates instructors in the same region advocate adding thoracic rotation and gentle back-extension work—like the “thread the needle” and “dart” exercises—to counteract the postural collapse of long desk hours. These interventions, they stress, are not merely palliative; they aim to strengthen the musculature that protects joints and the spine.

In parallel, a neurological perspective from Argentina frames the brain as a target organ of oestrogen loss. Neurologist Conrado Estol, in a widely circulated clinical commentary, argues that women under 60 or within ten years of menopause onset should be evaluated for hormone replacement therapy, citing improvements in hot flushes, sleep, and the “brain fog” of impaired memory and concentration. He notes that contraindications are rare, and that transdermal oestrogen with progesterone can yield measurable cognitive and quality-of-life gains. Brazilian endocrinologists, however, caution that hormonal investigation must rule out thyroid dysfunction, insulin resistance, and polycystic ovary syndrome before attributing weight or pain symptoms solely to menopause.

The next factual milestone is the wider integration of individualised metabolic and musculoskeletal assessments into routine menopause care. Clinical guidelines from orthopaedic academies already recommend exercise as first-line treatment for lumbar pain, while hormone therapy protocols are being refined to balance symptom relief against long-term risk. The convergence of these approaches—strength and mobility work for joints, metabolic screening for weight gain, and targeted hormone support—marks a shift from treating isolated symptoms to addressing the systemic physiology of midlife female ageing.